Gordon Gary B.
SEC Form 4 insider trading activity
Gordon Gary B. has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: May 18, 2026.
On the most recent filing, Gordon Gary B. is listed as Director at TriSalus Life Sciences, Inc. Inside the rolling window, Gordon Gary B. reported 2 open-market purchases totaling $65K in TLSI and no open-market sales. The largest disclosed transaction in the window is a purchase of 9,756 TLSI shares on Feb 23, 2026, worth $40K.
Companies traded
Other insiders at TLSI
Insider Buying
$65K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Gordon Gary B. made?
Gordon Gary B. has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Gordon Gary B. trade?
Gordon Gary B. has filed SEC Form 4 disclosures for 1 company, including TLSI.
When was Gordon Gary B.'s most recent SEC Form 4 filing?
Gordon Gary B.'s most recent SEC Form 4 filing on Tracefour is dated May 18, 2026.
What is Gordon Gary B.'s total buy and sell value in the current window?
Inside the rolling retention window, Gordon Gary B. bought $65K and sold $0 based on SEC Form 4 filings.
What was Gordon Gary B.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 9,756 TLSI shares on 2026-02-23, worth $40K, per SEC Form 4 filings.